diazoxide has been researched along with losartan potassium in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Anagnostou, A; Baranowski, R; Fried, W; Kurtzman, N; Pillay, VK; Vercellotti, G | 1 |
Akcil, E; Dalgic, A; Kaya, EE; Kocak, M; Salman, B; Yazihan, N; Yilmaz, TU | 1 |
Lazar, HL | 1 |
Aftab, M; Cleveland, JC; Eldeiry, M; Fullerton, DA; Mares, J; Meng, X; Reece, TB; Ryan, TJ; Weyant, MJ; Yamanaka, K | 2 |
Aftab, M; Eldeiry, M; Fullerton, DA; Meng, X; Reece, TB; Ryan, TJ; Weyant, MJ; Yamanaka, K | 1 |
7 other study(ies) available for diazoxide and losartan potassium
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of renin on extrarenal erythropoietin production.
Topics: Angiotensin II; Animals; Blood Pressure; Diazoxide; Erythropoietin; Female; Hypoxia; Mice; Mice, Inbred Strains; Nephrectomy; Proteins; Rats; Renin; Time Factors | 1976 |
Role of ATP-dependent K channels in the effects of erythropoietin in renal ischaemia injury.
Topics: Apoptosis; Cell Line; Cell Proliferation; Diazoxide; Erythropoietin; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; KATP Channels; Kidney; Kidney Diseases; Kidney Tubules; Reperfusion Injury | 2015 |
Pretreatment with diazoxide and erythropoietin: A novel strategy to prevent paraplegia after aortic surgery.
Topics: Diazoxide; Erythropoietin; Humans; Paraplegia; Spinal Cord | 2018 |
Optimized induction of beta common receptor enhances the neuroprotective function of erythropoietin in spinal cord ischemic injury.
Topics: Animals; Diazoxide; Erythropoietin; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Receptors, Erythropoietin; Signal Transduction; Spinal Cord; Spinal Cord Injuries; Spinal Cord Ischemia | 2018 |
Synergistic Reduction of Apoptosis With Diazoxide and Erythropoietin in Spinal Cord Ischemic Injury.
Topics: Animals; Apoptosis; Diazoxide; Erythropoietin; Mice; Receptors, Erythropoietin; Spinal Cord Ischemia; Up-Regulation | 2018 |
Synergetic Induction of NGF With Diazoxide and Erythropoietin Attenuates Spinal Cord Ischemic Injury.
Topics: Animals; Aortic Aneurysm, Thoracic; Diazoxide; Disease Models, Animal; Drug Synergism; Erythropoietin; Humans; Male; Mice; Nerve Growth Factor; Paraplegia; Recombinant Proteins; Spinal Cord; Spinal Cord Ischemia; Up-Regulation; Vascular Surgical Procedures | 2019 |